Micronoma in the News

Micronoma, a San Diego company, says its technology picks up signs of very early cancer from disrupted microbiome. Many researchers and companies are chasing the dream of detecting biomarkers of solid tumors in the blood, either to guide treatment, discover the cancer...

NEW YORK – Microbial cancer detection firm Micronoma said Tuesday that it is collaborating with... Read Article

After controlling for high levels of bacterial contamination in their lab and reagents, researchers detect microbial genetic material in plasma samples from healthy people and cancer patients. Read the full article in The Scientist

Read the article at CIO Applications

SAN DIEGO, Calif., Nov. 5, 2020 /PRNewswire/ -- Micronoma, an early-stage cancer detection biotech company seeking to develop and commercialize a minimally-invasive, unique microbiome-based assay, today announced their company expansion with three key executive...

Read the full article on GenomeWeb.

Microbiomics is taking a sharp turn. Until now, the field was limited to fecal transplants from healthy patients to those with gut conditions. The transplant is an awkward procedure that also creates regulatory and other challenges. Read More.

A San Diego-based biotech firm that has co-founders from UC San Diego is working to develop and commercialize a minimally invasive method for early cancer detection and recently closed a $3 million seed financing round to further its results. Read full story at La...

  NEW YORK – Following a successful $3 million seed funding round earlier this month, University of California, San Diego spinout Micronoma is commercializing a blood-based diagnostic assay that identifies a patient's organ microbiome signature to potentially...

San Diego-based Micronoma closed $3 million in seed financing to support the development of its microbiome-based cancer detection technology. Full Article

13 Aug. 2020. A new company, spun off from university biomedical engineering labs, is creating early cancer diagnostics by analyzing microbial genetics in simple blood samples. Micronoma, in San Diego, is also raising $3 million in its seed funding round, equity...

San Diego-based Micronoma, a startup working on early cancer detection, announced this morning that it has raised $3M in a seed financing round. The funding was led by SymBiosis, LLc. According to the company, Read Article

The story behind this paper begins with the loss of my grandmother to pancreatic cancer and the relentless pursuit to understand her disease. Projects along my educational path seemed like diversions (e.g. infectious disease genomics) but provided valuable skills to...

From a simple blood draw, microbial DNA may reveal who has cancer and which type, even at early stages When Gregory Poore was a freshman in college, his otherwise healthy grandmother was shocked to learn that she had late-stage pancreatic cancer. The condition was...